成人颈动脉夹层的治疗与结局:美国心脏协会科学声明
该科学声明概述了颈动脉夹层的诊断评估、治疗和结局,重点总结1990年1月1日至2022年12月31日文献证据并提出建议。对 eligible 的急性缺血性卒中患者,溶栓和机械取栓是合理的;抗栓治疗选择应个体化并至少持续3至6个月;复发夹层风险低,诊断后早期可考虑预防措施并在高危患者中继续。
要点
- 对因颈动脉夹层导致急性缺血性卒中且其他方面符合条件的患者,溶栓和机械取栓是合理的。
- 建议抗栓治疗选择个体化,并至少持续3至6个月。
- 复发夹层风险低,诊断后早期可考虑预防措施并在高危患者中继续。
核心结论
- 颈动脉夹层是卒中重要原因,尤其在年轻成人中;诊断评估和治疗数据存在冲突导致实践差异。
研究设计与样本
- 美国心脏协会写作组成员基于1990年1月1日至2022年12月31日的文献检索撰写各节,检索包括随机对照试验、前瞻性和回顾性观察研究、Meta分析、意见性论文、病例系列和病例报告。
主要发现
- 颈动脉夹层由危险因素、轻微创伤、解剖和先天异常及遗传易感性之间的相互作用所致。
- 诊断在临床和影像学上均可能具有挑战性。
- 复发夹层风险低。
关键数值与推荐
- 对因颈动脉夹层导致急性缺血性卒中且其他方面符合条件的患者,溶栓和机械取栓等急性治疗策略是合理的。
- 建议抗栓治疗选择个体化,并至少持续3至6个月。
- 诊断后早期可考虑预防措施,并在高危患者中继续。
临床怎么用
- 对因颈动脉夹层导致急性缺血性卒中且其他方面符合条件的患者,可考虑溶栓和机械取栓。
- 抗栓治疗选择应个体化,并至少持续3至6个月。
- 诊断后早期可考虑预防措施并在高危患者中继续。
局限性
- 需要正在进行的纵向和基于人群的观察性研究来弥补目前关于首选抗栓方案的差距,考虑颈动脉夹层的临床和影像学预后因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cervical artery dissection is an important cause of stroke, particularly in young adults. Data conflict on the diagnostic evaluation and treatment of patients with suspected cervical artery dissection, leading to variability in practice. We aim to provide an overview of cervical artery dissection in the setting of minor or no reported mechanical trigger with a focus on summarizing the available evidence and providing suggestions on the diagnostic evaluation, treatment approaches, and outcomes. Writing group members drafted their sections using a literature search focused on publications between January 1, 1990, and December 31, 2022, and included randomized controlled trials, prospective and retrospective observational studies, meta-analyses, opinion papers, case series, and case reports. The writing group chair and vice chair compiled the manuscript and obtained writing group members' approval. Cervical artery dissection occurs as a result of the interplay among risk factors, minor trauma, anatomic and congenital abnormalities, and genetic predisposition. The diagnosis can be challenging both clinically and radiologically. In patients with acute ischemic stroke attributable to cervical artery dissection, acute treatment strategies such as thrombolysis and mechanical thrombectomy are reasonable in otherwise eligible patients. We suggest that the antithrombotic therapy choice be individualized and continued for at least 3 to 6 months. The risk of recurrent dissection is low, and preventive measures may be considered early after the diagnosis and continued in high-risk patients. Ongoing longitudinal and population-based observational studies are needed to close the present gaps on preferred antithrombotic regimens considering clinical and radiographic prognosticators of cervical artery dissection.
引用
- Yaghi S, Engelter S, Del Brutto VJ, et al. Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association. Stroke. 2024. PMID: 38299330. doi:10.1161/STR.0000000000000457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。